Today’s Dividend Alert: Dec 20, 2016 will introduce $0.29 dividends for investors in Teva Pharmaceutical Industries Limited (NYSE:TEVA).

Today's Dividend Alert: Dec 20, 2016 will introduce $0.29 dividends for investors in Teva Pharmaceutical Industries Limited (NYSE:TEVA).

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is expected to pay $0.29 on Dec 20, 2016. The indicated annual dividend is $1.16. Shareholders owning the stock before Dec 1, 2016 will be eligible to receive the payout. Based on Teva Pharmaceutical Industries Limited’s current price of $37.80, the dividend is 0.76%. This dividend’s record date is Dec 5, 2016 and the announcement date is Nov 17, 2016. About 1,354 shares traded hands. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 32.67% since April 27, 2016 and is downtrending. It has underperformed by 37.90% the S&P500.

Teva Pharmaceutical Industries Limited is a global pharmaceutical company. The company has a market cap of $38.29 billion. The Firm is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. It has a 21.87 P/E ratio. The Firm operates through two divisions: Generic medicines and Specialty medicines.

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) Ratings Coverage

Out of 22 analysts covering Teva Pharma (NYSE:TEVA), 13 rate it a “Buy”, 0 “Sell”, while 9 “Hold”. This means 59% are positive. $86 is the highest target while $40 is the lowest. The $66.07 average target is 74.79% above today’s ($37.8) stock price. Teva Pharma has been the topic of 40 analyst reports since July 21, 2015 according to StockzIntelligence Inc. The firm earned “Buy” rating on Tuesday, July 28 by Citigroup. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Wednesday, November 16. On Monday, December 7 the stock rating was initiated by Mizuho with “Buy”. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Positive” rating given on Thursday, September 29 by OTR Global. JP Morgan reinitiated the stock with “Overweight” rating in Monday, August 3 report. The firm has “Outperform” rating given on Thursday, July 14 by Oppenheimer. Deutsche Bank maintained Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) rating on Tuesday, July 28. Deutsche Bank has “Buy” rating and $82 price target. The firm earned “Outperform” rating on Tuesday, July 21 by Leerink Swann. Maxim Group maintained the stock with “Buy” rating in Wednesday, November 16 report. Jefferies reinitiated Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Friday, October 30 with “Buy” rating.

More recent Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) news were published by: Investorplace.com which released: “Marijuana News: Teva Pharmaceuticals Industries Ltd (ADR) Signs Cannabis …” on November 28, 2016. Also Investorplace.com published the news titled: “Why Nokia Corp (ADR) (NOK), Teva Pharmaceutical Industries Ltd (ADR) (TEVA …” on November 15, 2016. Finance.Yahoo.com‘s news article titled: “TEVA : Summary for Teva Pharmaceutical Industries – Yahoo Finance” with publication date: July 13, 2016 was also an interesting one.

TEVA Company Profile

Teva Pharmaceutical Industries Limited, incorporated on February 13, 1944, is a global pharmaceutical company. The Firm is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Firm operates through two divisions: Generic medicines and Specialty medicines. The Firm has a global portfolio of approximately 1,000 molecules.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment